Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Xa”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT02596555
What this trial is testing

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

Who this might be right for
Pulmonary Embolism
Prof. Stavros Konstantinides, MD 400
Post-approval studies (Phase 4)Enrolling By InvitationNCT06862726
What this trial is testing

Apixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation

Who this might be right for
Non Valvular Atrial Fibrillation
Les Laboratoires des Médicaments Stériles 120
Post-approval studies (Phase 4)UnknownNCT03120715
What this trial is testing

Pregnancy Outcome of Women Using Low Molecular Weight Heparin Before Frozen-thawed Embryo Transfer

Who this might be right for
Infertility
Nanfang Hospital, Southern Medical University 342
Not applicableStudy completedNCT06484634
What this trial is testing

Role of Low-Molecular-Weight Heparin in Unexplained Recurrent Pregnancy Loss

Who this might be right for
Pregnancy Loss
RESnTEC, Institute of Research 175
Not applicableLooking for participantsNCT03659708
What this trial is testing

Pregnancy and Risk of Venous Thromboembolism

Who this might be right for
ThromboembolismPregnancy
Hospices Civils de Lyon 600
Testing effectiveness (Phase 2)Ended earlyNCT01532544
What this trial is testing

Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

Who this might be right for
Pneumonia
Thrombologic ApS 5
Testing effectiveness (Phase 2)Study completedNCT00462852
What this trial is testing

Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerThromboembolism
Hull University Teaching Hospitals NHS Trust 120
Not applicableStudy completedNCT02925247
What this trial is testing

Specific Anti Factor Xa Activity Dosage to Enhance Detection of Nonadherence in Atrial Fibrillation Patients

Who this might be right for
Atrial Fibrillation
Assistance Publique Hopitaux De Marseille 150
Very early researchStudy completedNCT02704052
What this trial is testing

Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose

Who this might be right for
Deep Venous ThrombosisPulmonary EmbolusVenous Thromboembolism
University of Utah 116
Testing effectiveness (Phase 2)WithdrawnNCT04275778
What this trial is testing

HYDROxychloroquine in Syndrome Primary AntiPhospholipid

Who this might be right for
Antiphospholipid Syndrome in PregnancyAnticoagulants
Assistance Publique - Hôpitaux de Paris
Not applicableNot Yet RecruitingNCT07213713
What this trial is testing

Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.

Who this might be right for
Venous ThromboembolismObese Patients
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Large-scale testing (Phase 3)Ended earlyNCT01164046
What this trial is testing

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Who this might be right for
Venous ThromboembolismNeoplasms
University Medical Center Groningen 56
Post-approval studies (Phase 4)Study completedNCT00689520
What this trial is testing

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Who this might be right for
Venous Thromboembolism
Hospital Universitari de Bellvitge 241
Large-scale testing (Phase 3)Study completedNCT00003674
What this trial is testing

Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Alliance for Clinical Trials in Oncology 141
Testing effectiveness (Phase 2)Study completedNCT00398216
What this trial is testing

DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Who this might be right for
ThrombosisHip Replacement
Daiichi Sankyo 903
Large-scale testing (Phase 3)Ended earlyNCT01356992
What this trial is testing

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation

Who this might be right for
Non ST Segment Elevation Myocardial InfarctionUnstable Angina
Eurofarma Laboratorios S.A. 62
Large-scale testing (Phase 3)Study completedNCT01880216
What this trial is testing

Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT

Who this might be right for
Deep Vein Thrombosis
Berlin-Chemie AG Menarini Group 312
Post-approval studies (Phase 4)Ended earlyNCT00445328
What this trial is testing

Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

Who this might be right for
Venous Thromboembolism
Pfizer 84
Post-approval studies (Phase 4)Study completedNCT01687491
What this trial is testing

Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeFactor X
Les Laboratoires des Médicaments Stériles 179
Post-approval studies (Phase 4)UnknownNCT01970280
What this trial is testing

Low Molecular Weight Heparin in Prevention of Recurrent Arteriovenous Graft Thrombosis in Chronic Hemodialysis Patients.

Who this might be right for
Hemodialysis Patients
Dr. Sidney Ben Chetrit 26
Next Page